UK markets closed

NeoGenomics, Inc. (NEO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
14.03-0.13 (-0.92%)
At close: 04:00PM EDT
14.03 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.81B
Enterprise value 2.00B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.00
Price/book (mrq)1.92
Enterprise value/revenue 3.39
Enterprise value/EBITDA -113.83

Trading information

Stock price history

Beta (5Y monthly) 1.10
52-week change 3-1.67%
S&P500 52-week change 325.01%
52-week high 321.22
52-week low 311.03
50-day moving average 315.07
200-day moving average 315.46

Share statistics

Avg vol (3-month) 3907.22k
Avg vol (10-day) 3704.39k
Shares outstanding 5127.67M
Implied shares outstanding 6127.67M
Float 8125.95M
% held by insiders 11.18%
% held by institutions 1101.03%
Shares short (28 Mar 2024) 47.24M
Short ratio (28 Mar 2024) 49.07
Short % of float (28 Mar 2024) 47.88%
Short % of shares outstanding (28 Mar 2024) 45.67%
Shares short (prior month 29 Feb 2024) 47.01M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -14.87%
Operating margin (ttm)-11.17%

Management effectiveness

Return on assets (ttm)-3.50%
Return on equity (ttm)-9.07%

Income statement

Revenue (ttm)591.64M
Revenue per share (ttm)4.71
Quarterly revenue growth (yoy)12.10%
Gross profit (ttm)N/A
EBITDA -23.16M
Net income avi to common (ttm)-87.97M
Diluted EPS (ttm)-0.70
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)415.2M
Total cash per share (mrq)3.25
Total debt (mrq)611.68M
Total debt/equity (mrq)64.97%
Current ratio (mrq)6.20
Book value per share (mrq)7.39

Cash flow statement

Operating cash flow (ttm)-1.95M
Levered free cash flow (ttm)289.62k